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Abstract
Background: Granulomatosis with polyangiitis is a rare multisystemic autoimmune disorder predominantly
affecting the upper and lower respiratory tracts and the kidneys, and rarely affecting other organ systems.
Tuberculosis can mimic the presentation of granulomatosis with polyangiitis, and both can occur simultaneously in
the same patient. Here we report what we believe to be the first case of concurrent granulomatous breast lesions
and hemorrhagic retinal angiopathy in a Sri Lankan woman with refractory granulomatosis with polyangiitis
complicated by probable tuberculosis.
Case presentation: A 48-year-old Sri Lankan Moorish woman presented with a 6-month history of ulcerating
bilateral breast lumps, a 3-month history of non-healing painful ulcers on the palate, and sudden bilateral painless
loss of vision. Retinoscopy confirmed left-sided retinal hemorrhages and bilateral panuveitis. An examination of her
respiratory system showed bilateral coarse crepitations. Histologic examination of the palatal and breast lesions
showed chronic granulomatous inflammation. Her levels of immune markers were elevated but her renal function
was normal. Chest radiography showed bilateral mid-zone and lower-zone infiltrates with cavitation and small
pleural effusions. Her serum proteinase 3 anti-neutrophil cytoplasmic antibody titer and the level of adenosine
deaminase in her pleural fluid were significantly elevated. She was diagnosed with generalized granulomatosis
with polyangiitis complicated with probable pulmonary tuberculosis, and was started on methylprednisolone and
cyclophosphamide pulse therapy with anti-tuberculous treatment. She later developed cerebral vasculitis, indicating
refractory disease, and was treated with second-line rituximab with excellent response.
Conclusion: Proteinase 3 anti-neutrophil cytoplasmic antibody may be a valuable diagnostic marker in patients
with atypical symptoms of granulomatosis with polyangiitis or in the presence of probable tuberculosis. Retinal
vascular angiopathy needs to be diagnosed and treated early to prevent the development of complete blindness.
Concomitant cytotoxic and anti-tuberculous treatments may be safe and effective in patients with simultaneous
refractory disease with probable tuberculosis.
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Background
Granulomatosis with polyangiitis (GPA), also known as
Wegener’s granulomatosis, is a rare multisystem auto-
immune disorder predominantly affecting the upper and
lower respiratory tracts and the kidneys [1]. It has a
spectrum of clinical presentations, and new manifesta-
tions may appear during the course of the disease. Nec-
rotizing granulomatous inflammation and vasculitis of
small and medium blood vessels are characteristics of
this disorder. Proteinase 3 anti-neutrophil cytoplasmic
antibody (PR3-ANCA) is strongly associated with GPA,
and over 90 % of patients have been reported to demon-
strate ANCA positivity during active disease [2]. About
30 cases of breast granulomatosis have been reported in
association with GPA to date, but a concurrent associ-
ation with hemorrhagic retinal angiopathy has not been
reported [3–6]. GPA can affect any part of the eye, and
one previous study described the case of a patient pre-
senting with hemorrhagic retinal angiopathy as the first
clinical sign [7]. Tuberculosis (TB) can mimic the
* Correspondence: vipbat7@yahoo.com
1Department of Pharmacology and Pharmacy, Faculty of Medicine University
of Colombo, PO Box 271, Kynsey Road, Colombo 08, Sri Lanka
Full list of author information is available at the end of the article
© 2015 Bataduwaarachchi et al. Open Access This article is distributed under the terms of the Creative Commons Attribution
4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Bataduwaarachchi et al. Journal of Medical Case Reports  (2015) 9:296 
DOI 10.1186/s13256-015-0792-4
pulmonary symptoms of GPA, and their simultaneous
occurrence can thus lead to diagnostic confusion and
consequent management challenges.
Here, we report what we believe to be the first case of
concurrent granulomatous breast lesions and hemorrhagic
retinal angiopathy, which occurred in a Sri Lankan
woman with refractory GPA complicated with probable
pulmonary TB.
Case presentation
A 48-year-old Sri Lankan Moorish woman from
Colombo presented to our emergency treatment unit
with bilateral sudden-onset painless loss of vision. There
was no associated tearing, irritation, or red eyes. Six
months previously she had noted bilateral, slowly grow-
ing breast lumps for which she has not taken medical
advice, on cultural grounds. The lumps subsequently be-
came ulcerated, with intense pain and discomfort (Fig. 1).
She also complained of painful non-healing ulcers in her
palate over the previous 3 months, with no associated
anogenital ulceration (Fig. 2). Background constitutional
symptoms had been present for 1 year, but the results of
the rest of her systemic review were normal. After ad-
mission, she developed a dry cough and moderate
hemoptysis without fever. She had no family or contact
history of TB, and no family history of malignancies or
autoimmune disorders.
A general examination revealed that our patient was of
average build with no lymphadenopathy. She did not
consent to a genital examination. An examination of her
respiratory system showed bilateral diffuse coarse crepi-
tations. There was no dullness over her lung fields and
no bronchial breathing was present. Her skin and nails
appeared normal with no stigmata of chronic disease.
Results from cardiovascular, rheumatological, and neuro-
logical examinations were normal.
Visual assessment
Our patient’s light perception was absent bilaterally
and she had no direct or indirect light reflexes, sug-
gesting a bilateral visual pathway lesion. Results from
magnetic resonance imaging of her brain and orbits
were normal, excluding any gross abnormality of the
posterior visual pathway. Indirect retinoscopy showed
retinal hemorrhage due to retinal vascular angiopathy
in her left retina with bilateral panuveitis (Fig. 3). Vis-
ual evoked potentials were unrecordable on both
sides, further supporting this diagnosis.
Laboratory assessment
Our patient’s immune markers were elevated, with an
erythrocyte sedimentation rate of 135 mm/h and C-
reactive protein level of 96 mg/dL. Chest radiography
showed bilateral mid-zone and lower-zone infiltrates
with cavitation and small pleural effusions (Fig. 4).
Contrast-enhanced thoracic computed tomography con-
firmed the presence of multifocal alveolar infiltrates, cav-
itations, and effusions (Fig. 5). A Mantoux test was not
performed because she had undergone one previously,
though the results were not available. Although a γ-
interferon-release assay would have been useful, we did
not have the facilities to perform this investigation. A
sputum acid-fast bacilli (AFB) test was negative in three
consecutive samples. The difference between her serum
and pleural fluid protein levels was 15 g/L and the differ-
ential lymphocyte count was 70 %. Her lactate dehydro-
genase level was 600 U/L in her pleural fluid. Results
from cytology, Gram staining, AFB, and TB polymerase
Fig. 1 Appearance of the right breast after wound cleaning.
A large ulcer is visible destroying the nipple and areola. Sutures
were placed to oppose the gaping edges of the wound. A few
granulomatous whitish papules are visible projecting out from the
subcutaneous tissues
Fig. 2 Appearance of the palate after wound cleaning and biopsy.
A large ulcer (1.5 × 1.3 cm) with a sharp edge and unhealthy base
covered with slough is seen at the margin between the soft and
hard palates on the right side. A smaller similar ulcer is present on
the left side. A suture was placed at the biopsy site
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chain reaction and cultures of the pleural fluid were
negative.
An ultrasound scan of her breast showed multiple
hypoechoic ill-defined areas suggestive of abscesses. A bi-
opsy of the abscess wall showed well-formed granulomas
with collections of histiocytes and multinucleated giant
cells. There was no caseation to indicate TB or cytological
abnormalities suggestive of malignancy. Histologic examin-
ation of the palatal ulcers indicated a similar pattern of
granulomatous inflammation with some necrotic areas.
Screening for human immunodeficiency virus was negative
and her normal levels of angiotensin-converting enzyme
excluded sarcoidosis. Her renal function and results of a
full urine report were normal. However, her serum PR3-
ANCA titer was significantly elevated at 190.74 IU/mL
(normal <20 IU/L) although her myeloperoxidase-
neutrophil cytoplasmic antibody, anti-nuclear antibody,
and rheumatoid factor titers were all normal. Her pleural
fluid adenosine deaminase (ADA) level was significantly el-
evated at 101 IU/L (normal <2 IU/mL).
Diagnosis
The pulmonary and oral manifestations together with
strong positivity for PR3-ANCA confirmed the diagnosis
of generalized GPA in our patient [8]. This was associated
with rare manifestations of breast granulomatosis and
hemorrhagic retinal angiopathy. However, renal involve-
ment, which indicates a poor prognosis, was absent [9].
Significantly elevated pleural fluid ADA together with cav-
itating lung lesions suggested probable concurrent TB. TB
commonly causes upper lobe lung cavitation, compared
with mid-zone and lower-zone cavitations that are more
common in GPA. Our patient refused to have a pleural/
lung biopsy, which would have provided histological and/
or microbiological confirmation of TB. According to the
Fig. 3 Indirect retinoscopy image at presentation. A large retinal hemorrhage is present around the left optic disc. Pre-retinal retrohyaloidal
hemorrhages and segmental perivascular changes are also visible
Fig. 4 Chest radiography at presentation. Multiple nodular and
cavitating lesions are visible predominately on the right side with
multiple patchy infiltrates typical of granulomatosis with polyangiitis.
Costophrenic angles are obliterated owing to small bi-basal
pleural effusions
Fig. 5 Contrast-enhanced thoracic computed tomography at
presentation. Multifocal alveolar infiltrates are visible
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consultant chest physician’s opinion, we considered prob-
able coexisting TB based on her markedly high pleural
fluid ADA levels. Initiation of cytotoxic treatment pre-
sented a management dilemma in our patient because of
the presence of organ-threatening GPA.
Therapy and follow-up
Our patient was started on intravenous methylpredniso-
lone (1,000 mg/day for 3 days) and intravenous cyclo-
phosphamide at a dose of 15 mg/kg every 2 weeks for
the first three pulses, followed by infusions every 3
weeks for the next 3–6 pulses, as per European League
Against Rheumatism recommendations [10]. She was
also started on full anti-tuberculous therapy (ATT) with
rifampicin 5 mg/kg, isoniazid 10 mg/kg, pyrazinamide
30 mg/kg, and ethambutol 15 mg/kg with pyridoxine, as
per World Health Organization guidelines. Her pulmon-
ary, breast, and oral lesions slowly improved, but her vi-
sion did not recover. Her liver and renal functions were
closely monitored. After completing 2 months of treat-
ment she presented with sudden-onset generalized tonic
clonic convulsions. Brain magnetic resonance imaging
indicated multiple infarctions, suggesting possible cere-
bral vasculitis, though results from a magnetic resonance
arteriogram and magnetic resonance venogram were
normal. Tests for anti-phospholipid antibodies were
negative, excluding the possibility of coexisting anti-
phospholipid syndrome. Refractory disease was consid-
ered and she was started on second-line rituximab 375
mg/m2 by intravenous infusion once weekly for 4 weeks,
with intravenous methylprednisolone 1,000 mg/day for 3
days followed by prednisone 1 mg/kg per day [11, 12].
Aspirin 75 mg was started daily. Complete clinical re-
mission was achieved, though her vision did not recover,
probably because of permanent damage to the retina.
She continued with ATT for 6 months on the basis of
probable TB, with resolution of the pulmonary lesions.
Our patient was referred to a rehabilitation program to
address her blindness.
Discussion
We believe this is the first reported case of concurrent
granulomatous breast lesions and vasculitis-like
hemorrhagic retinal angiopathy in a patient with GPA.
The presence of ADA-positive cavitating lung lesions
suggested probable TB, even though this was not con-
firmed by microbiological tests. Given that the radio-
logical pattern of the pulmonary lesions was indicative
of GPA, in the absence of a tissue diagnosis our patient
was considered to have coexisting pulmonary TB on the
basis of pleural fluid ADA. The prevalence of TB in
urban Sri Lanka (13.9 %) is higher than in rural areas
(2.2 %) [13], possibly associated with poor housing con-
ditions, especially in some areas in Colombo. It was
therefore reasonable to consider the probability of TB in
this patient. Even though TB can present with chronic
oral ulceration and breast granulomatosis, histologic
examination of the lesions from our patient showed
well-formed granulomas with multinucleate giant cells
and histiocytes, in contrast to the caseation seen in TB.
The presence of blindness and organ-threatening GPA
created a management challenge in terms of the timing
of cytotoxic treatment in our patient. We opted to treat
both conditions simultaneously, with close monitoring
of organ function. The appearance of a new symptom
complex of multiple infarctions on magnetic resonance
imaging raised the possibility of treatment for refractory
disease. Our patient showed an excellent clinical re-
sponse to second-line rituximab in the absence of renal
involvement. The recent RITUXVAS trial, which was
conducted among patients with newly diagnosed GPA or
microscopic polyangiitis with renal involvement, found
no difference between the rituximab and control groups,
while B-cell return was associated with relapse [14].
Although TB can be associated with elevated serum
PR3-ANCA levels, the histology in the current case was
more indicative of GPA than TB [15]. The interpretation
of elevated ADA levels in the absence of a tissue diagno-
sis is controversial, and ATT with immunosuppression is
justifiable. In our case, it resulted in a marked clinical
and radiological response [16]. Previous results regard-
ing concomitant ATT and cytotoxic treatment in similar
presentations further support this treatment strategy in
our patient [17, 18]. The prognosis for patients treated
with rituximab for rheumatoid arthritis in the presence
of TB has been shown to be excellent, though the
current case is the first to report the use of rituximab
with appropriate ATT cover in a patient with both TB
and refractory GPA [19]. Further studies are needed to
determine the long-term outcomes and optimal treat-
ment regimens to be used under similar circumstances.
Conclusions
Although GPA affecting the breast is rare, it should
nonetheless be considered in the evaluation of any
breast mass. Retinal vascular angiopathy needs to be di-
agnosed and treated early to prevent the development of
complete blindness. A full systemic evaluation is thus es-
sential in patients diagnosed with GPA. Sarcoidosis, im-
mune deficiency, and disseminated malignancy should
be excluded in a patient presenting with breast lumps;
pulmonary and ocular lesions, the nature of the lesions,
histological results, and biomarkers are important for
making a differential diagnosis in such cases. PR3-
ANCA is a valuable diagnostic marker in patients with
atypical symptoms of GPA or concurrent similar illness
such as TB. Simultaneous cytotoxic treatment, including
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rituximab, and ATT can be safe and effective in patients
with refractory GPA and probable TB.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Abbreviations
ADA: Adenosine deaminase; AFB: Acid fast bacilli; ATT: anti-tuberculosis
treatment; GPA: granulomatosis with polyangiitis; PR3-ANCA: proteinase 3
anti-neutrophil cytoplasmic antibody; TB: tuberculosis.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
VRB participated in the management of this patient and drafted the
manuscript. RG helped in the management decision-making and the
preparation of the manuscript. NT was involved in the overall supervision,
management of this patient, and review of the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
We thank consultant chest physicians and consultant ophthalmologists who
provided support in the management of this patient.
Author details
1Department of Pharmacology and Pharmacy, Faculty of Medicine University
of Colombo, PO Box 271, Kynsey Road, Colombo 08, Sri Lanka. 2Department
of Medicine, National Hospital, Ward Place, Colombo 07, Sri Lanka.
Received: 2 April 2015 Accepted: 11 December 2015
References
1. Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, et al.
Granulomatosis with polyangiitis (Wegener’s): an alternative name for
Wegener's granulomatosis. Ann Rheum Dis. 2011;63:863–4.
2. Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA,
et al. ANCA are detectable in nearly all patients with active severe
Wegener’s granulomatosis. Am J Med. 2007;120:643. e9–14.
3. Neralić-Meniga I, Ivanovi-Herceg Z, Mazuranić I, Puljić I, Zekan M, Gorecan
M, et al. Wegener’s granulomatosis of the breast. Wien Klin Wochenschr.
2006;118:120–3.
4. Barczyńska T, Dankiewicz-Fares I, Bilińska-Reszkowska H, Zalewska J, Jeka S.
Atypical location of Wegener’s granulomatosis with breast involvement:
case report. Ann Acad Med Stetin. 2011;57:70–6.
5. Szabo-Moskal J. Wegener’s granulomatosis of the breast: a case report. Pol J
Radiol. 2014;79:117–19.
6. Allende DS, Booth CN. Wegener’s granulomatosis of the breast: a rare entity
with daily clinical relevance. Ann Diagn Pathol. 2009;13:351–7.
7. Matlach J, Freiberg FJ, Gadeholt O, Göbel W. Vasculitis-like hemorrhagic
retinal angiopathy in Wegener’s granulomatosis. BMC Res Notes. 2013;6:364.
8. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The
American College of Rheumatology 1990 criteria for the classification of
Wegener’s granulomatosis. Arthritis Rheum. 1990;33:1101–7.
9. Andrassy K, Erb A, Koderisch J, Waldherr R, Ritz E. Wegener’s granulomatosis
with renal involvement: patient survival and correlations between initial
renal function, renal histology, therapy and renal outcome. Clin Nephrol.
1991;35:139–47.
10. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al.
EULAR recommendations for the management of primary small and
medium vessel vasculitis. Ann Rheum Dis. 2009;68:310–7.
11. Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, et al.
Rituximab for the treatment of relapses in antineutrophil cytoplasmic
antibody-associated vasculitis. Arthritis Rheumatol. 2014;66:3151–9.
12. Aldasoro-Cáceres V, Aldasoro-Cáceres I, Pérez-Moreiras JV, Murié-Fernández
M, Ibáñez-Bosch R. C-ANCA positive necrotizing scleritis and multiple
sclerosis compatible with ocular Wegener: treatment with rituximab. Arch
Soc Esp Oftalmol. 2014;89:31–4.
13. Wijesinghe PR, Palihawadana P, De Alwis S, Samaraweera S. Annual risk of
tuberculosis infection in Sri Lanka: a low prevalent country with a high BCG
vaccination coverage in the South-East Asia Region. WHO South-East Asia J
Public Health. 2013;2:34–40 [Abstract].
14. Jones RB, Furuta S, Cohen Tervaert JW, Hauser T, Luqmani R, Morgan MD, et al.
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year
results of a randomised trial. Ann Rheum Dis. 2015;74:1178–82.
15. Ulises Martínez-Martínez M, Gómez-Gómez A, Oros-Ovalle C, Abud-Mendoza C.
A 44 year-old-man with cavitary pulmonary disease. Reumatol Clin. 2013;9:62–4.
16. Kubota M, Katagiri M, Yanase N, Soma K, Tomita T. Measurement of
adenosine deaminase activity in bronchoalveolar lavage fluids as a tool
for diagnosing miliary tuberculosis. Nihon Kyobu Shikkan Gakkai Zasshi.
1996;34:139–44.
17. Mauricio Morales Cadena G, Morales Rivera LI, Tapia Álvarez L, Zubiaur
Gomar F, Martínez Gallardo F. Tuberculosis y granulomatosis de Wegener
en otorrinolaringología. Anales de Otorrinolaringología. 2012;4:236–45.
18. Ihsaan A-H, Taha O. TB or not TB: that is the question. Respir Med CME.
2010;3:192–94.
19. Latorre MC, Valero Y. Rituximab in patients with tuberculosis disseminate
and latent tuberculosis (TB): follow up 3 years. Clínica de Artritis y
Rehabilitación, Bogotá Colombia. Poster presentation at EULAR 2009; June
10–13; Copenhagen, Denmark. http://cayre.co/conozca-cayre/investigacion/
pub/82-rituximab-in-patients-with-tuberculosisdisseminate-and-latent-follow-
up-3-years. Accessed 04 Apr 2015
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Bataduwaarachchi et al. Journal of Medical Case Reports  (2015) 9:296 Page 5 of 5
